Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H21N5O3S |
Molecular Weight | 399.467 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(CSCCNC2=NC=C(CC3=CC=C4OCOC4=C3)C(=O)N2)N=CN1
InChI
InChIKey=YTBDPHYVGACIPC-UHFFFAOYSA-N
InChI=1S/C19H21N5O3S/c1-12-15(23-10-22-12)9-28-5-4-20-19-21-8-14(18(25)24-19)6-13-2-3-16-17(7-13)27-11-26-16/h2-3,7-8,10H,4-6,9,11H2,1H3,(H,22,23)(H2,20,21,24,25)
Molecular Formula | C19H21N5O3S |
Molecular Weight | 399.467 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Mechanism of oxmetidine (SK&F 92994) cytotoxicity in isolated rat hepatocytes. | 1985 Jun |
|
Oxmetidine in the short term treatment of active duodenal ulcer. A review and commentary. | 1989 |
|
Mechanism of inhibition of rat liver mitochondrial respiration by oxmetidine, an H2-receptor antagonist. | 1990 Mar |
|
Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings. | 2010 Dec |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2861279
Oxmetidine (50 microM) blocked pyruvate/malate-supported state 3 (ADP-stimulated) respiration, caused a decrease in the ADP:0 ratio and a loss of respiratory control in isolated rat liver mitochondria.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 14:58:39 GMT 2023
by
admin
on
Fri Dec 15 14:58:39 GMT 2023
|
Record UNII |
Z504D030RF
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
72830-39-8
Created by
admin on Fri Dec 15 14:58:39 GMT 2023 , Edited by admin on Fri Dec 15 14:58:39 GMT 2023
|
PRIMARY | |||
|
51710
Created by
admin on Fri Dec 15 14:58:39 GMT 2023 , Edited by admin on Fri Dec 15 14:58:39 GMT 2023
|
PRIMARY | |||
|
C170273
Created by
admin on Fri Dec 15 14:58:39 GMT 2023 , Edited by admin on Fri Dec 15 14:58:39 GMT 2023
|
PRIMARY | |||
|
C027703
Created by
admin on Fri Dec 15 14:58:39 GMT 2023 , Edited by admin on Fri Dec 15 14:58:39 GMT 2023
|
PRIMARY | |||
|
SUB09544MIG
Created by
admin on Fri Dec 15 14:58:39 GMT 2023 , Edited by admin on Fri Dec 15 14:58:39 GMT 2023
|
PRIMARY | |||
|
4928
Created by
admin on Fri Dec 15 14:58:39 GMT 2023 , Edited by admin on Fri Dec 15 14:58:39 GMT 2023
|
PRIMARY | |||
|
DTXSID30223149
Created by
admin on Fri Dec 15 14:58:39 GMT 2023 , Edited by admin on Fri Dec 15 14:58:39 GMT 2023
|
PRIMARY | |||
|
276-926-6
Created by
admin on Fri Dec 15 14:58:39 GMT 2023 , Edited by admin on Fri Dec 15 14:58:39 GMT 2023
|
PRIMARY | |||
|
100000083070
Created by
admin on Fri Dec 15 14:58:39 GMT 2023 , Edited by admin on Fri Dec 15 14:58:39 GMT 2023
|
PRIMARY | |||
|
CHEMBL2110657
Created by
admin on Fri Dec 15 14:58:39 GMT 2023 , Edited by admin on Fri Dec 15 14:58:39 GMT 2023
|
PRIMARY | |||
|
7847
Created by
admin on Fri Dec 15 14:58:39 GMT 2023 , Edited by admin on Fri Dec 15 14:58:39 GMT 2023
|
PRIMARY | |||
|
Z504D030RF
Created by
admin on Fri Dec 15 14:58:39 GMT 2023 , Edited by admin on Fri Dec 15 14:58:39 GMT 2023
|
PRIMARY | |||
|
OXMETIDINE
Created by
admin on Fri Dec 15 14:58:39 GMT 2023 , Edited by admin on Fri Dec 15 14:58:39 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |